MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0006054
Disto Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹22.63 Cr
▼ 5% YoY
Net profit · FY 2024
₹10.08 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹2.7 Cr
EBITDA margin 11.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.56 Cr
Issued & subscribed
Open charges
₹18.87 Cr
Satisfied ₹1.95 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
75
Provident fund records
About Disto Pharmaceuticals Private Limited
Data last updated:
Disto Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 May 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2002PTC038926. Its GSTIN is 36AABCD4970C1ZW (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.56 Cr. It is led by directors including Asith Kumar Mukherjee (Managing Director) and Bidesh Mukherjee (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.63 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹10.08 Lakh (net margin 0.4%) and EBITDA of ₹2.7 Cr (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 8% over five years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Disto Pharmaceuticals. As per MCA filings, the company has open charges of ₹18.87 Cr and satisfied charges of ₹1.95 Cr on record.
Disto Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0006054). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website distopharma.com.
Company details
CIN U24239TG2002PTC038926
Registration Number 038926
Incorporation Date 09 May 2002
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0006054
CIN history
Disto Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2002PTC038926. The current CIN is U24239TG2002PTC038926, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2002PTC038926 | Current |
| U24239AP2002PTC038926 | Previous |
Key People
Asith Kumar Mukherjee Managing Director Bidesh Mukherjee Whole-Time Director Krishna Raj Pandey Whole-Time Director Recognitions & Rankings of Disto Pharmaceuticals
Contact details
Disto Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is distopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Disto Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Disto Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Disto Pharmaceuticals operates one associated brand: Disto Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures pharmaceutical pellets, granules, tablets, and capsules. | distopharma.com |
Business activity
The main business activity of Disto Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Disto Pharmaceuticals Private Limited, buy the company report.
Financials of Disto Pharmaceuticals Private Limited
FY 2024 filings availableDisto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr (down 5% YoY) for FY 2024.
Revenue · FY 2024
₹22.63 Cr ▼ 5%
Net profit · FY 2024
₹10.08 Lakh margin 0.4%
EBITDA · FY 2024
₹2.7 Cr margin 11.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 8%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▼ 11%
5 years · compounded
▲ 10%
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Disto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asith Kumar Mukherjee Also directs: Vive Medsolutions Private Limited | Managing Director | 15 Sep 2009 | 17 Years 1 Months | Current |
| Harish Chandra Pandey Also directs: Vive Medsolutions Private Limited | Director | 15 Sep 2009 | 17 Years 1 Months | Current |
| Bidesh Mukherjee | Whole-Time Director | 15 Oct 2022 | 4 Years 0 Months | Current |
| Krishna Raj Pandey | Whole-Time Director | 15 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Disto Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wallace Laboratories Private Limited | ₹22.71 Cr (FY 2023) | 27.0% | Goa, India | |||
| Dr. Smiths Biotech Private Limited | ₹22.7 Cr (FY 2023) | 40.0% | Pune, Maharashtra, India | |||
| Astamed Healthcare ( India ) Private Limited | ₹22.66 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Disto Pharmaceuticals Private Limitedthis company | ₹22.63 Cr (FY 2024) | ₹10.08 Lakh | 0.4% | -5.0% | 75 | Hyderabad, Telangana, India |
| Parul Pharmaceuticals Private Limited | ₹22.59 Cr (FY 2024) | 62.0% | Vadodara, Gujarat, India | |||
| Mapaex Remedies Private Limited | ₹22.57 Cr (FY 2017) | -52.0% | Wadhwan, Gujarat, India | |||
| Athulitha Laboratories Private Limited | ₹22.56 Cr (FY 2024) | 66.0% | Hyderabad, Telangana, India | |||
| Beryl Drugs Limited | ₹22.55 Cr (FY 2025) | -17.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Disto Pharmaceuticals Private Limited, buy the company report.
Auditor
Disto Pharmaceuticals Private Limited is audited by DHANUNJAYA & HARANATH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHANUNJAYA & HARANATH | FY 2023 | 206446 |
Shareholding
The shareholding of Disto Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Disto Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.87 Cr
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Oct 2025 | 101171460 | Uco Bank | ₹9.61 Cr | Open | |
| 03 Dec 2024 | 101054918 | Uco Bank | ₹84 Lakh | Open | |
| 18 Sep 2024 | 100982787 | Uco Bank | ₹11.8 Lakh | Open | |
| 05 Jul 2024 | 100970273 | Hdfc Bank Limited | ₹17.5 Lakh | Open | |
| 28 May 2024 | 100949760 | Hdfc Bank Limited | ₹22.05 Lakh | Open |
To see the full charge records of Disto Pharmaceuticals Private Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
No court or tribunal cases involving Disto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Disto Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 15 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Chemical Enterprises | |||
| an individual supplier | |||
| S. Zhaveri Pharmakem Private Limited | |||
| an individual supplier | |||
| Mak Clean Air Systems Private Limited |
To see the full MSME payment records of Disto Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Disto Pharmaceuticals Private Limited has a workforce of 75 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
75
Active EPFO establishments
1
Employee growth
20.97%
GST
Disto Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCD4970C1ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Disto Pharmaceuticals Private Limited, buy the company report.
Recent activity
Disto Pharmaceuticals Private Limited has 10 board changes on record since 2009: 4 appointments and 6 cessations. The latest: Bidesh Mukherjee ceased to be Additional Director on 28 Apr 2023.
Charges
A charge with Uco Bank amounted to Rs. 9.61 Cr with Charge ID 101171460 was registered on 09 Oct 2025.
Charges
A charge with Uco Bank amounted to Rs. 0.84 Cr with Charge ID 101054918 was registered on 03 Dec 2024.
AGM
Disto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Uco Bank amounted to Rs. 0.12 Cr with Charge ID 100982787 was registered on 18 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100970273 was registered on 05 Jul 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100949760 was registered on 28 May 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.42 Cr with Charge ID 100949727 was registered on 08 May 2024.
Filing
Disto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Uco Bank of Rs. 6.74 Cr registered on 07 May 2021 with Charge ID 100449155 was modified on 30 Dec 2023.
Ceased
Bidesh Mukherjee ceased to be Additional Director.
Ceased
Krishna Raj Pandey ceased to be Additional Director.
Charges
A charge registered on 10 Oct 2019 via Charge ID 100299623 with Uco Bank was fully satisfied on 03 Apr 2023.
17 earlier events are in the company report.
Frequently asked questions
Disto Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 May 2002 (24+ years old) and is registered under CIN U24239TG2002PTC038926.
Disto Pharmaceuticals has 4 current directors:
- Asith Kumar Mukherjee - Managing Director
- Bidesh Mukherjee - Whole-Time Director
- Krishna Raj Pandey - Whole-Time Director
- Harish Chandra Pandey - Director
The latest financial statements of Disto Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Disto Pharmaceuticals is 36AABCD4970C1ZW, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Disto Pharmaceuticals is U24239TG2002PTC038926. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Disto Pharmaceuticals was incorporated on 09 May 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Disto Pharmaceuticals by revenue are Wallace Laboratories Private Limited, Dr. Smiths Biotech Private Limited, Astamed Healthcare ( India ) Private Limited, Parul Pharmaceuticals Private Limited, Mapaex Remedies Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bidesh Mukherjee ceased to be Additional Director on 28 Apr 2023. Krishna Raj Pandey ceased to be Additional Director on 28 Apr 2023. Bidesh Mukherjee was appointed as Whole-Time Director on 15 Oct 2022. Disto Pharmaceuticals has 10 board changes on record in total.
Yes, Disto Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0006054).
Disto Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 15 overdue payments to 15 micro and small suppliers. The latest return was filed on 31 May 2019.
Disto Pharmaceuticals can be reached through the website distopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Disto Pharmaceuticals is at Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051.